NEW YORK (GenomeWeb News) - Gene Logic said today that it will work with the US Food and Drug Administration to develop quality control metrics that will help the agency assess the quality of genomic data submissions.

 

The collaboration is part of FDA's Critical Path Initiative. Gene Logic said that the collaboration's results will be released publicly as "an early step towards formulating industry-wide standards" for assessing genomic data. The company said that there are currently no such standards in place.